logo
logo

Cambridge Epigenetix Raises $88 Million Series D Financing To Advance Best-In-Class Dna Sequencing Technology Platform

Cambridge Epigenetix Raises $88 Million Series D Financing To Advance Best-In-Class Dna Sequencing Technology Platform

11/02/21, 7:30 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
$88 million
Round Type
series d
Cambridge Epigenetix (CEGX), a life sciences tools and technology company revolutionizing genome sequencing, today announced the signing of an $88 million Series D financing, bringing the total funds raised to date to $146 million. Temasek led the Series D round with participation from new investors including Third Point and existing investors such as GV, New Science Ventures, Ahren Innovation Capital and Sequoia.

Company Info

Company
Cambridge Epigenetix
Location
cambridge, maryland, united states
Additional Info
The firm often engages with company managements and boards to improve performance and will also take passive stakes in companies with a long-term view of value creation.